Skip to main content
Clinical Trials/ITMCTR2200006377
ITMCTR2200006377Not yet recruitingPhase 1

Clinical study on the treatment of Cervical Spondylosis of vertebral artery Type with Sun Meridian Needle knife

Gansu provincial hospital of traditional Chinese medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
30 to 65 (—)
Sex
All

Inclusion Criteria

  • (1) Those who meet the above diagnostic criteria;
  • (2) Those who are between 30-65 years old, regardless of gender;
  • (3) Those whose disease course is less than 1 year;
  • (4) Those whose vertigo score in ESCV scale is 2-6 points ;
  • (5) Those who can tolerate and agree to acupotomy treatment or receive flunarizine hydrochloride capsules treatment; (6) Those who can cooperate with examination, adhere to treatment, and cooperate with curative effect observation and complete follow-up;
  • (7) Voluntarily sign the informed consent form And strictly abide by this researcher.

Exclusion Criteria

  • (1) Combined with cervical spondylosis of nerve root type, sympathetic nerve type, spinal type, and esophageal type;
  • (2) Vertigo caused by otogenic, ophthalmic and other causes;
  • (3) Vertebral artery and basilar artery caused by other diseases Abnormal hemodynamic changes;
  • (4) patients with acute and chronic infection of neck skin;
  • (5) patients with severe heart, liver, kidney, blood system, malignant tumor and other primary diseases;
  • (6) pregnant women Or those who are allergic to flunarizine hydrochloride capsules;
  • (7) Those who are intolerant or afraid of acupuncture treatment; (8) Those who have serious mental illness.

Investigators

Sponsor
Gansu provincial hospital of traditional Chinese medicine

Similar Trials

Clinical study on the treatment of... | Clinical Trial